论文信息 - Assessment of Low Dose Vigil ® Engineered Autologous Tumor Cell ( EATC ) Immunotherapy in Patients with Advanced Solid Tumors - 字舞流文

Assessment of Low Dose Vigil ® Engineered Autologous Tumor Cell ( EATC ) Immunotherapy in Patients with Advanced Solid Tumors

D. Rao | N. Senzer | J. Nemunaitis | B. Pappen | M. Barve | Jonathan C Oh | Padmasini Kumar | N. Taquet | G. Wallraven | E. Mendeloff | L. Manning | E. Bognar | Jonathan C. Oh